Articles On Uscom (ASX:UCM)

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off a major profit drop Qantas saw a 28pc drop in profit but saw modest share price gains   The ASX was sluggish on Thursday, down 0.33%, follo...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Not much in the way of headline news, but the market plodded along ASX 200 closes down -0.12pc, despite a push for Health and the Goldies Who won the Small Caps race today? Read on to find out…   It’s not been the busiest of news days, bu...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Echo IQ is awaiting FDA approval for its AI-powered EchoSolv platform EchoSolv utilises machine learning algorithms to detect aortic stenosis Stockhead reached out to Echo IQ’s COO, Deon Strydom   When looking at a healthcare stock to buy...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

Local markets end slightly higher IT Sector slumps 1.2pc Small Caps led by AT1   The ASX 200 traded sideways again today, closing the day +0.1% higher as gains in Financials and Real Estate were offset by losses in Tech and Mining stocks....

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

When the US sneezes economically, the rest of the world catches a cold. But when China sniffles, Australia is at risk of a full-blown bout of influenza. Last week the China gloom amped up a notch on reports of global banks cutting their gro...

ASX 200 climbs about 0.8% on a happier day than yesterday Unemployment jump to 3.7% in January eases concern over future rate rise severity NSW Government’s coal policy kicks miners square in the cokers   Good afternoon, and welcome to th...

Aussie markets end Friday on a -0.80% disappointment US signals new cannabis laws, good news for Aussie producers Zelensky the hot tip to win a rare mid-war Nobel Peace Prize   The ASX has dribbled  it’s way towards Friday’s -0.80% close,...

Uscom’s device is included in China’s emergency guidelines Poland provides grant for Immutep’s Phase 2 trial Medical device company Uscom (ASX:UCM) said that it has been included in the national emergency medicine guidelines for acute hea...

Uscom (UCM) receives Chinese regulatory National Medical Products Administration (NMPA) acceptance for four devices in its range of SpiroSonic spirometers This acceptance comes after more than two years of national testing by the regulator...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

In October, the Chinese government released its intellectual proprietary (IP) patents strategy paper, listing its main goals for the next five years. Part of that plan is to double the foreign “high value” patents from the current 40,000 to...

It’s only just ticked into November but it’s starting to feel a bit like Christmas – and the tail end of the pandemic, as nations re-open their doors and borders. But we will be dealing with the health consequences of Covid for years to com...

After yesterday’s drop, risk-on sentiment returned to Australia’s bourse today. The ASX 200 rose 0.9% to 7,327 points while the ASX Emerging Companies Index rose 0.3% to 2,167 points. Energy surprisingly dropped 1.91% after gaining substant...

The change from one financial year to the next saw several ASX company directors sell to pay forthcoming tax bills but also purchases as directors betted on the future. Code Company Director Change Date Volume $ What LGL Ly...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX has begun the week in positive territory, albeit only slightly. The ASX 200 closed at 7,046 points, 0.22 per cent higher than Friday. The ASX Emerging Companies Index however retreated 0.35 per cent, closing at 2,114. The best secto...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

The Uscom Ltd (ASX: UCM) share price tumbled today after the company released its quarterly cash report, showing significant falls across every major category. The Uscom share price was down 6% at the close of trade today, at 15.5 cents pe...

Source: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the launch of NOBLE Registry of its prostate cancer imaging agent. Global healthcare company Ramsay Health Care confirms the funding guarantee arr...

China’s economy is forecast to grow at a rate of 7 to 9 per cent in 2021, according to consensus estimates Chinese households and consumers have amassed a pool of wealth amid China’s economic rise and have spare cash to spend Several ASX c...

Medical device manufacturer Uscom Ltd (ASX: UCM) has today announced a significant increase in its sales and profits for the first 5 months of FY21. The Uscom share price lifted by 10% after the announcement, and is currently trading at 17...

Summary Uscom Limited informed the market today that Uscom China got listed as a National High Technology Enterprise. The National High Technology Entities are recognised as a national value. They are offered special assistance by seve...

A quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 715 stocks rose, 639 decl...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Our summary of Uscom Ltd's recent announcement What's happened? Uscom Limited (ASX:UCM) today announced the signing of a development and supply agreement with A&D Limited of Japan. What are the key highlights? The agreement relates to...

The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

The spread of coronavirus has infected global share markets with the contagion of fear. The S&P/ASX 200 Index (INDEXASX: XJO) has fallen more than 10% in the last fortnight as investors flee to safe havens. This week, the Reserve Bank...

In February, mounting coronavirus-led uncertainty finally culminated in a late-month share price bloodbath. After a 3 per cent gain in January, the S&P/ASX Emerging Companies Index – which gauges the health of the microcap sector – had...

Last week markets had their worst week since the global financial crisis (GFC) and the carnage, at least on the ASX, continued yesterday. A virus that began at a live meat market in Wuhan has now spread to over 80,000 people globally and th...

The Uscom Ltd (ASX: UCM) share price rocketed higher today following the announcement that the Chinese government has recommended one of its products for use in treating coronavirus. After surging as much as 38.7% in afternoon trade, Uscom...

Australian medical technology company Uscom (ASX: UCM) has posted a 35% drop in total revenue figures for the half-year ending December 2019, underpinned by a restructure to its China-based distribution model. In January, the company commis...

For weeks Zoono (ASX:ZNO) shares have surged as people demand its products wanting to protect themselves from the coronavirus, but maybe this wasn’t panic buying after all. This morning the hand sanitiser maker revealed the test results of...

As the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a global health emergency, share markets are feeling the impact of the outbreak with Australian ASX-listed stocks not immune to the damage. C...